If they put all the MS drugs, and all the cancer drugs, and all the HIV drugs on the same cost-tier plan, they're really not discriminating against one disease group. They're discriminating against anyone who must depend on higher-cost drugs. |
It's a concern that this may be opening a larger black hole where we see a lot of cost shifting to people who are chronically ill. |